A Pan-cancer Screening and Diagnosis Model Based on Abdominal CT Was Established

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorXiangdong Cheng

About this trial

Abdominal noncontrast scan and contrast-enhanced CT were used to establish a screening and diagnostic model for abdominal tumors

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

all patients were pathologically diagnosed with abdominal tumors;

The clinical case data of all patients were complete, and complete follow-up was obtained, with clear information on medical visits, operation time and survival status within 2 years. If the cause of death is unknown, it will be recorded as censored data;

All patients had no history of active abdominal bleeding, no serious infection or other abdominal diseases that affected the observation of CT imaging within 3 months before surgery.

all patients have complete clinical case data, complete abdominal CT, no history of malignant tumors, no serious infections or other abdominal diseases that affect the diagnosis and observation of CT imaging.

Disqualifiers

Cases in which contrast-enhanced or noncontrast CT images show unclear lesions, with significant noise and artifacts;

Trial population

Patients with abdominal tumors or Non-tumor population

Trial design

Design model

Case-only

Time perspective

Retrospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Whether or not there is a diagnosis of abdominal tumor questionnaire

Whether or not there is a diagnosis of abdominal tumor

Time frame
first visited at baseline

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Xiangdong Cheng

Lead sponsor

Zhejiang Cancer Hospital

Sponsor institution